J&J Finishes Tough Year With Optimism For 2021
J&J expects its medical device sales to begin growing rapidly by the middle of 2021 as the pandemic subsides.
You may also be interested in...
Despite Crisis In Some Areas, Analysts Do Not Expect Delta To Derail Recovery
Numbers of COVID-19 patients in the hospital are rising in many states and a few hospitals have been stretched to their limit, but data compiled by Credit Suisse suggests that the surgical capacity of US hospitals will stabilize in September.
J&J Continues Momentum In Second Quarter
Johnson & Johnson’s medical device sales were up nearly 60% year-over-year in the second quarter of 2021 while Abbott reported 51% growth in its device business, reflecting the recovery in procedure volumes since the worst days of the pandemic in mid-2020.
CMR Surgical Closes SoftBank-Led Funding Round Worth $600M
CMR Surgical has raised $600m to globally commercialize its Versius surgical robotics platform.